+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticancer Agent"

Liver Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Liver Cancer Treatment Drugs Markets in China

  • Report
  • September 2023
  • 239 Pages
  • China
From
2023 Global Prescription Pharmaceuticals and Medicine Products-Consumer Products Forecasts Database Subscription - Product Thumbnail Image

2023 Global Prescription Pharmaceuticals and Medicine Products-Consumer Products Forecasts Database Subscription

  • Database
  • July 2023
  • Global
From
Methionine Aminopeptidase 2 - Pipeline Review, H2 2019 - Product Thumbnail Image

Methionine Aminopeptidase 2 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 62 Pages
  • Global
From
Targeted Oncology Therapeutics: Hematology Cancers - Product Thumbnail Image

Targeted Oncology Therapeutics: Hematology Cancers

  • Report
  • October 2021
  • 110 Pages
  • Global
From
Taxane Antineoplastic Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Taxane Antineoplastic Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • March 2024
  • 115 Pages
  • Global
From
Plant Sources Anti Cancer Agent Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Plant Sources Anti Cancer Agent Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • March 2024
  • 138 Pages
  • Global
From
Antineoplastic Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Antineoplastic Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • June 2023
  • 119 Pages
  • Global
From
Anti-Neoplastic Agents Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Anti-Neoplastic Agents Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • June 2023
  • 104 Pages
  • Global
From
Cytotoxic Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Cytotoxic Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 91 Pages
  • Global
From
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H1 2018 - Product Thumbnail Image

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H1 2018

  • Drug Pipelines
  • June 2018
  • 123 Pages
  • Global
From
Bromodomain Containing Protein 2 (Really Interesting New Gene 3 Protein or O27.1.1 or BRD2) - Pipeline Review, H1 2018 - Product Thumbnail Image

Bromodomain Containing Protein 2 (Really Interesting New Gene 3 Protein or O27.1.1 or BRD2) - Pipeline Review, H1 2018

  • Drug Pipelines
  • May 2018
  • 50 Pages
  • Global
From
Proto Oncogene Tyrosine Protein Kinase ROS - Pipeline Review, H1 2020 - Product Thumbnail Image

Proto Oncogene Tyrosine Protein Kinase ROS - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 90 Pages
  • Global
From
NT 3 Growth Factor Receptor - Pipeline Review, H2 2019 - Product Thumbnail Image

NT 3 Growth Factor Receptor - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 74 Pages
  • Global
From
Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach - Product Thumbnail Image

Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach

  • Book
  • November 2023
Herbal Medicine: Back to the Future - Cancer Therapy - Product Thumbnail Image

Herbal Medicine: Back to the Future - Cancer Therapy

  • Book
  • September 2019
  • 302 Pages
From
Pharmaceuticals Markets in China - Product Thumbnail Image

Pharmaceuticals Markets in China

  • Report
  • February 2024
  • 275 Pages
  • China
From
Anti-Tumor Drugs Markets in China - Product Thumbnail Image

Anti-Tumor Drugs Markets in China

  • Report
  • November 2023
  • 214 Pages
  • China
From
Anti-Tumor Drugs Companies in China - Product Thumbnail Image

Anti-Tumor Drugs Companies in China

  • Report
  • November 2023
  • 65 Pages
  • China
From
Liver Cancer Treatment Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Liver Cancer Treatment Drugs Industry Forecasts - China Focus

  • Report
  • September 2023
  • 121 Pages
  • China
From
2023 Global Forecast For Anti-Neoplastic Agents, including Radioactive Isotopes, and Specific Anti-Neoplastic Agents (2023-2028 Outlook) - Manufacturing & Markets Report - Product Thumbnail Image

2023 Global Forecast For Anti-Neoplastic Agents, including Radioactive Isotopes, and Specific Anti-Neoplastic Agents (2023-2028 Outlook) - Manufacturing & Markets Report

  • Report
  • November 2022
  • 132 Pages
  • Global
From
Loading Indicator

The Anticancer Agent market is a segment of the Healthcare Services industry that focuses on the development and distribution of drugs and treatments for cancer. These agents are designed to target and destroy cancer cells while minimizing the damage to healthy cells. They can be administered orally, intravenously, or topically, depending on the type of cancer and the patient's individual needs. Anticancer agents are used in combination with other treatments such as radiation and chemotherapy to provide the best possible outcome for the patient. The Anticancer Agent market is highly competitive, with many companies vying for market share. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more